CSTF3
Basic information
Region (hg38): 11:33077188-33162371
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CSTF3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 0 | 0 |
Variants in CSTF3
This is a list of pathogenic ClinVar variants found in the CSTF3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-33085143-C-T | not specified | Uncertain significance (Feb 14, 2023) | ||
11-33085191-C-T | not specified | Uncertain significance (Nov 18, 2023) | ||
11-33085223-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
11-33085733-C-T | not specified | Uncertain significance (Jan 24, 2023) | ||
11-33085902-C-T | not specified | Uncertain significance (Dec 16, 2021) | ||
11-33087024-G-C | not specified | Uncertain significance (Nov 14, 2023) | ||
11-33087084-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
11-33087098-A-G | not specified | Uncertain significance (Dec 08, 2023) | ||
11-33087131-C-G | not specified | Uncertain significance (Apr 07, 2023) | ||
11-33090671-A-C | not specified | Uncertain significance (Feb 11, 2022) | ||
11-33096365-T-G | not specified | Uncertain significance (Dec 28, 2022) | ||
11-33096866-G-C | not specified | Uncertain significance (Jun 06, 2023) | ||
11-33107982-T-A | not specified | Uncertain significance (Sep 22, 2023) | ||
11-33141716-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
11-33141741-G-A | not specified | Uncertain significance (Feb 02, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CSTF3 | protein_coding | protein_coding | ENST00000323959 | 21 | 85184 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.983 | 0.0172 | 125729 | 0 | 17 | 125746 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.94 | 113 | 386 | 0.293 | 0.0000206 | 4710 |
Missense in Polyphen | 15 | 78.08 | 0.19211 | 896 | ||
Synonymous | 1.43 | 104 | 124 | 0.836 | 0.00000625 | 1286 |
Loss of Function | 5.32 | 8 | 47.6 | 0.168 | 0.00000287 | 568 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000217 | 0.000217 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000721 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000807 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: One of the multiple factors required for polyadenylation and 3'-end cleavage of mammalian pre-mRNAs.;
- Pathway
- mRNA surveillance pathway - Homo sapiens (human);mRNA Processing;Gene expression (Transcription);polyadenylation of mrna;RNA Polymerase II Transcription;Metabolism of RNA;Processing of Intronless Pre-mRNAs;Processing of Capped Intronless Pre-mRNA;Cleavage of Growing Transcript in the Termination Region ;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3,-end processing;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.163
Intolerance Scores
- loftool
- 0.596
- rvis_EVS
- -0.63
- rvis_percentile_EVS
- 17.03
Haploinsufficiency Scores
- pHI
- 0.631
- hipred
- Y
- hipred_score
- 0.651
- ghis
- 0.674
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.985
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cstf3
- Phenotype
Zebrafish Information Network
- Gene name
- cstf3
- Affected structure
- anatomical system
- Phenotype tag
- abnormal
- Phenotype quality
- quality
Gene ontology
- Biological process
- mRNA splicing, via spliceosome;termination of RNA polymerase II transcription;mRNA polyadenylation;mRNA cleavage;RNA 3'-end processing;mRNA 3'-end processing
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA binding;mRNA binding;protein binding